Relationship between in-hospital angiotensin converting enzyme inhibitors and Angiotensin receptor blockers administration and delirium in the cardiac ICU

References

• Mulkey MA, Hardin SR, Olson DM, et al. Pathophysiology review: seven neurotransmitters associated with delirium. Clin Nurse Spec. 2018;32(4):195–211. doi: 10.1097/NUR.0000000000000384.
   PubMed Web of Science ®Google Scholar
• Zhang S, Han Y, Xiao Q, et al. Effectiveness of bundle interventions on ICU delirium: a meta-analysis. Crit Care Med. 2021;49(2):335–346. doi: 10.1097/CCM.0000000000004773
   PubMed Web of Science ®Google Scholar
• Zhang H, Yuan J, Chen Q, et al. Development and validation of a predictive score for ICU delirium in critically ill patients. BMC Anesthesiol. 2021;21(1):37. doi: 10.1186/s12871-021-01259-z
   PubMed Web of Science ®Google Scholar
• Ali MA, Hashmi M, Ahmed W, et al. Incidence and risk factors of delirium in surgical intensive care unit. Trauma Surg Acute Care Open. 2021;6(1):e000564. doi: 10.1136/tsaco-2020-000564
   PubMedGoogle Scholar
• Maldonado J. Acute brain failure: pathophysiology, diagnosis, management, and sequelae of delirium. Crit Care Clin. 2017;33(3):461–519. doi: 10.1016/j.ccc.2017.03.013
   PubMed Web of Science ®Google Scholar
• Maldonado JR. Neuropathogenesis of delirium: review of current etiologic theories and common pathways. Am J Geriatric Psychiatry. 2013;21(12):1190–1222. doi: 10.1016/j.jagp.2013.09.005
   PubMed Web of Science ®Google Scholar
• LaHue SC, Douglas VC, Kuo T, et al. Association between inpatient delirium and hospital readmission in patients ‚â• 65 years of age: a retrospective cohort study. J Hosp Med. 2019;14(4):201–206. doi: 10.12788/jhm.3130
   PubMed Web of Science ®Google Scholar
• Mulkey M, Khan S, Perkins A, et al. Relationship between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers use and delirium in the ICU. J Am Geriatr Soc. 2023;71(6):1873–1880. IN PRESS. doi: 10.1111/jgs.18285
   PubMed Web of Science ®Google Scholar
• Mulkey MA, Khan S, Perkins A, et al. Relationship between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prescribing and delirium in the ICU-A secondary analysis. J Am Geriatr Soc. 2023;71(6):1873–1880. doi: 10.1111/jgs.18285
   PubMed Web of Science ®Google Scholar
• Maldonado JR. Delirium pathophysiology: an updated hypothesis of the etiology of acute brain failure. Int J Geriatr Psychiatry. 2018;33(11):1428–1457. doi: 10.1002/gps.4823
   PubMed Web of Science ®Google Scholar
• Mulkey M, Everhart DE, Gencarelli A, et al. A review of neuronal pathways associated with consciousness. J Neurosci Nurs. 2021;53(1):39–43. doi: 10.1097/JNN.0000000000000559
   PubMed Web of Science ®Google Scholar
• Schreuder L, Eggen BJ, Biber K, et al. Pathophysiological and behavioral effects of systemic inflammation in aged and diseased rodents with relevance to delirium: a systematic review. Brain Behav Immun. 2017;62:362–381. doi: 10.1016/j.bbi.2017.01.010
   PubMed Web of Science ®Google Scholar
• Ouk M, Wu C-Y, Rabin JS, et al. The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status. Alzheimer’s Res Ther. 2021;13(1):43. doi: 10.1186/s13195-021-00778-8
   PubMed Web of Science ®Google Scholar
• Dézsi CA. Differences in the clinical effects of angiotensin-converting enzyme inhibitors and Angiotensin receptor blockers: a critical review of the evidence. Am J Cardiovasc Drugs. 2014;14(3):167–173. doi: 10.1007/s40256-013-0058-8
   PubMed Web of Science ®Google Scholar
• Ho JK, Moriarty F, Manly JJ, et al. Blood-brain barrier crossing renin-angiotensin drugs and cognition in the elderly: a meta-analysis. Hypertension. 2021;78(3):629–643. doi: 10.1161/HYPERTENSIONAHA.121.17049
   PubMed Web of Science ®Google Scholar
• Farag E, Liang C, Mascha EJ, et al. Association between use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and postoperative delirium. Anesthesiology. 2020;133(1):119–132. doi: 10.1097/ALN.0000000000003329
   PubMed Web of Science ®Google Scholar
• Farag E, Sessler DI, Ebrahim Z, et al. The renin angiotensin system and the brain: new developments. J Clin Neurosci. 2017;46:1–8. doi: 10.1016/j.jocn.2017.08.055
   PubMed Web of Science ®Google Scholar
• Nation DA, Sweeney MD, Montagne A, et al. Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nature Med. 2019;25(2):270–276. doi: 10.1038/s41591-018-0297-y
   PubMed Web of Science ®Google Scholar
• Chen R, Suchard MA, Krumholz HM, et al. Comparative first-line effectiveness and safety of ACE (Angiotensin-Converting Enzyme) inhibitors and angiotensin receptor blockers: a multinational cohort study. Hypertension. 2021;78(3):591–603. doi: 10.1161/HYPERTENSIONAHA.120.16667
   PubMed Web of Science ®Google Scholar
• Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). JAMA. 2001;286(21):2703–2710. doi: 10.1001/jama.286.21.2703
   PubMed Web of Science ®Google Scholar
• Boettger S, Meyer R, Richter A, et al. Delirium in the intensive care setting dependent on the Richmond Agitation and Sedation Scale (RASS): inattention and visuo-spatial impairment as potential screening domains. Pall Supp Care. 2020;18(2):148–157. doi: 10.1017/S1478951519000683
   PubMed Web of Science ®Google Scholar
• El Sheikh WG, Sleem B, Kobeissy F, et al. Biomarkers of delirium and relation to dementia among the elderly in the intensive care unit: a narrative review. Biomark Neuropsychiatry. 2023;8:100064. doi: 10.1016/j.bionps.2023.100064
   Google Scholar
• Khaksari M, Rajizadeh MA, Bejeshk MA, et al. Does inhibition of angiotensin function cause neuroprotection in diffuse traumatic brain injury? Iran J Basic Med Sci. 2018;21(6):615–620. doi: 10.22038/IJBMS.2018.26586.6512
   PubMed Web of Science ®Google Scholar